VOICED : Rusia aprueba producción en Argentina de escasa segunda dosis de vacuna Sputnik V

Argentina received authorization from the Gamaleya Institute to produce the second dose of the Sputnik V vaccine. The Russian Direct Investment Fund and Argentine laboratory Richmond announced that the locally produced vaccine will be available next week after quality control tests. This comes after Argentina's complaints about delays in receiving the second dose. Richmond plans to produce over three million doses in August and will start supplying 150,000 doses to the government. Argentina has an agreement with Russia for 30 million doses but has received less than 12 million. Sputnik V was the first COVID-19 vaccine registered globally, and Argentina was the first Latin American country to approve it. Despite being approved in 69 countries, it lacks WHO approval. Argentina is accelerating its vaccination campaign due to the delta variant threat and is conducting trials to mix vaccines to replace the second Sputnik V dose with AstraZeneca, Sinopharm, or Moderna.

Which organization authorized Argentina to produce the second dose of Sputnik V?

• Gamaleya Institute

• European Medicines Agency

• World Health Organization

• Centers for Disease Control and Prevention

What is the planned production quantity of the second component of Sputnik V by Richmond in August?

• Four million doses

• One million doses

• Two million doses

• Three million doses

How many doses of the second component of Sputnik V has Argentina received so far?

• Twelve million

• Two and a half million

• Five million

• Nine million

What is the reason for Argentina accelerating its vaccination campaign?

• Shortage of vaccines

• Increase in vaccine prices

• Approval from WHO

• Concerns about the Delta variant

Which vaccines are being considered in Argentina to replace the second dose of Sputnik V?

• Pfizer, Johnson & Johnson, AstraZeneca

• AstraZeneca, Sinopharm, Moderna

• Sinopharm, Johnson & Johnson, Moderna

• Moderna, Pfizer, Sinovac